(S)-(+)-NBD-APy,
143112-52-1,
(S)-(+)-4-(3-Amino-pyrrolidino)-7-nitrobenzofurazan,
(S)-(+)-4-Nitro-7-(3-aminopyrrolidin-1-yl)benzofurazan,
(S)-(+)-4-Nitro-7-(3-aminopyrrolidin-1-yl)-2,1,3-benzoxadiazole,
CTK4C3487,
DTXSID70576808,
ZINC6505629,
ANW-42992,
MFCD00191509,
AKOS027378228,
RTR-005503,
TR-005503,
J-007744,
(3S)-1-(7-Nitro-2,1,3-benzoxadiazol-4-yl)pyrrolidin-3-amine,
(S)-1-(7-Nitrobenzo[c][1,2,5]oxadiazol-4-yl)pyrrolidin-3-amine,
3-Pyrrolidinamine,1-(7-nitro-2,1,3-benzoxadiazol-4-yl)-, (3S)-,
(S)-(+)-NBD-APy [=(S)-(+)-4-Nitro-7-(3-aminopyrrolidin-1-yl)-2,1,3-benzoxadiazole] [HPLC Labeling Reagent for e.e. Determination],
QSDDQXROWUJAJX-LURJTMIESA-N,
A5562,
- -4-NITRO-7- -2,1,3-BENZOXADIAZOLE,